Accretion Pharmaceuticals Ltd
Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of Nifty SME Emerge
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Capacity Utilization - Capsules % ・Standalone data |
|
|||
| Capacity Utilization - External Preparations % ・Standalone data |
||||
| Capacity Utilization - Oral Liquid % ・Standalone data |
||||
| Capacity Utilization - Oral Powder % ・Standalone data |
||||
| Capacity Utilization - Tablets % ・Standalone data |
||||
| Direct Export Revenue Share % ・Standalone data |
||||
| Sales on Contract Manufacturing / Loan License Revenue Share % ・Standalone data |
||||
| Top 10 Customer Revenue Concentration % ・Standalone data |
||||
Extracted by Screener AI
Documents
Announcements
-
Shareholders meeting
3 August 2026 - Accretion Pharmaceuticals Limited has informed regarding Notice of Annual General Meeting to be held on August 27, 2026
-
Copy of Newspaper Publication
1 August 2026 - 3rd AGM on 27 August 2026 at 11:00 a.m. via VC/OAVM.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
7 July 2026 - Accretion Pharmaceuticals confirms Regulation 27(2) non-applicability for quarter ended 30 June 2026 on NSE SME.
-
Resignation of Director/KMP/SMP
6 July 2026 - Accretion Pharmaceuticals Limited has informed about Resignation of Director/KMP/SMP
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
6 July 2026 - Submitted Regulation 74(5) certificate for quarter ended 30 June 2026.
Concalls
-
May 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT REC
Business Profile[1]
The company manufactures pharmaceutical formulations, including both generic and branded products. It offers contract and third-party manufacturing services for domestic and international markets. Its clientele includes private institutions, government sectors (state and central), and reputed pharmaceutical companies.